Free Trial
NASDAQ:CELU

Celularity (CELU) Stock Price, News & Analysis

Celularity logo
$2.05 +0.02 (+0.99%)
Closing price 07/3/2025 03:50 PM Eastern
Extended Trading
$2.01 -0.04 (-1.95%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Celularity Stock (NASDAQ:CELU)

Key Stats

Today's Range
$1.96
$2.10
50-Day Range
$1.48
$2.49
52-Week Range
$1.00
$5.22
Volume
20,385 shs
Average Volume
338,543 shs
Market Capitalization
$49.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Celularity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

CELU MarketRank™: 

Celularity scored higher than 4% of companies evaluated by MarketBeat, and ranked 922nd out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Celularity.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Celularity is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Celularity is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Celularity has a P/B Ratio of 5.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Celularity's valuation and earnings.
  • Percentage of Shares Shorted

    10.43% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Celularity has recently decreased by 2.70%, indicating that investor sentiment is improving.
  • Dividend Yield

    Celularity does not currently pay a dividend.

  • Dividend Growth

    Celularity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.43% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 19, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Celularity has recently decreased by 2.70%, indicating that investor sentiment is improving.
  • News Sentiment

    Celularity has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Celularity this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Celularity insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.10% of the stock of Celularity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.02% of the stock of Celularity is held by institutions.

  • Read more about Celularity's insider trading history.
Receive CELU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celularity and its competitors with MarketBeat's FREE daily newsletter.

CELU Stock News Headlines

Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Celularity Terminates CFO David Beers
Celularity Announces Chief Financial Officer Transition
See More Headlines

CELU Stock Analysis - Frequently Asked Questions

Celularity's stock was trading at $2.08 at the start of the year. Since then, CELU shares have decreased by 1.4% and is now trading at $2.05.

Celularity, Inc. (NASDAQ:CELU) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.59) EPS for the quarter, beating the consensus estimate of ($1.50) by $0.91. The company earned $18.13 million during the quarter, compared to analyst estimates of $5.20 million. Celularity had a negative trailing twelve-month return on equity of 271.88% and a negative net margin of 106.77%.

Celularity shares reverse split before market open on Thursday, February 29th 2024.The 1-10 reverse split was announced on Thursday, February 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CELU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celularity investors own include NVIDIA (NVDA), Meta Platforms (META), Lovesac (LOVE), MannKind (MNKD), PayPal (PYPL), Tesla (TSLA) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/08/2025
Today
7/04/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELU
Fax
N/A
Employees
220
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.89 million
Net Margins
-106.77%
Pretax Margin
-106.77%

Debt

Sales & Book Value

Annual Sales
$54.22 million
Price / Cash Flow
N/A
Book Value
$0.37 per share
Price / Book
5.54

Miscellaneous

Free Float
18,656,000
Market Cap
$49.10 million
Optionable
Optionable
Beta
0.74
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:CELU) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners